Logo
N

Newcells Biotech

44 employees

Newcells Biotech are experts in the production of induced pluripotent stem cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Supply of iPSC derived cells for drug development
DIKI
Disease Modelling
Drug Induced Kidney Injury (DIKI)
Drug Transport Studies
Sourcing samples for human disease cell lines
Medical Device
Viral infection
RPE
Cellular reprogramming and differentiation
Nephrotoxity Testing
Proximal Tubule Model
Health Care
Induced pluripotent stem cells (iPSCs)
Lung Epithelia
ADMET
Retinal Epithelia
Therapeutics
Liver Sinusoid
Retinal Epithelial Model
Stem Cell Models
Medical

Date founded

2014

Funding rounds raised

Total raised

$7.1M

from 2 investors over 2 rounds

N

Newcells Biotech raised $7.1M on February 24, 2021

Investors: The North East Fund Ltd.

N

Newcells Biotech raised $2.6M on July 4, 2018

Investors: NVM Private Equity LLP

FAQ